Merck exec discussing use of COVID antiviral drug in Ebola responseMerck exec discussing use of COVID antiviral drug in Ebola response
Merck is in discussions with various global health authorities about making its COVID antiviral pill molnupiravir available as an Ebola treatment to address the widening outbreak in the Democratic Republic
